^
Association details:
Biomarker:CRBN overexpression
Cancer:Multiple Myeloma
Drug:thalidomide (TNF inhibitor)
Direction:Resistant
Evidence:
Evidence Level:
Resistant: C3 – Early Trials
Source:
Title:

EXPRESSION SIGNIFICANCE OF CRL4-CRBN PROTEINS COMPLEX IN MULTIPLE MYELOMA PATIENTS TREATED WITH IMMUNOMODULATORY DRUGS.

Published date:
05/14/2020
Excerpt:
The patients with high CRBN expression also had the higher level of monoclonal protein (p=0.004), the lower haemoglobin concentration (p=0.035) and poorer response to IMiDs treatment (p=0.034)…